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Presynaptic inhibition via G-protein-coupled receptors (GPCRs) and voltage-gated Ca2 channels constitutes a widespread regulatory
mechanism of synaptic strength. Yet, the mechanism of intermolecular coupling underlying GPCR-mediated signaling at central syn-
apses remains unresolved. Using FRET spectroscopy, we provide evidence for formation of spatially restricted (100 Å) complexes
between GABAB receptors composed of GB1a /GB2 subunits, Go12 G-protein heterotrimer, and CaV2.2 channels in hippocampal
boutons. GABA release was not required for the assembly but for structural reorganization of the precoupled complex. Unexpectedly,
GB1a deletion disrupted intermolecular associations within the complex. The GB1a proximal C-terminal domain was essential for asso-
ciation of the receptor, CaV2.2 andG, but was dispensable for agonist-induced receptor activation and cAMP inhibition. Functionally,
boutons lacking this complex-formation domain displayed impaired presynaptic inhibition of Ca2 transients and synaptic vesicle
release.Thus, compartmentalizationof theGABAB1a receptor,G, andCaV2.2 channel ina signaling complex is required forpresynaptic
inhibition at hippocampal synapses.
Introduction
G-protein-coupled receptors (GPCRs), G-proteins, and N- and
P/Q-type high-voltage-gated Ca2 (CaV) channels (Nowycky et
al., 1985) represent key signaling elements controlling Ca2 flux
at nerve terminals (Dunlap et al., 1995). Since the first work of
Dunlap and Fischbach (1978), numerous studies suggest that
GPCR activation induces inhibition of CaV channels via direct
interaction with G subunits of G-proteins (for review, see
Hille, 1994; Zamponi and Snutch, 1998; Catterall, 2000; Dolphin,
2003; De Waard et al., 2005). This membrane-delimited mecha-
nism of CaV channel inhibition has been proposed to enable
precise inhibition of neurotransmitter release in space and time.
Despite several decades of intensive research, the intermolec-
ular couplingmechanismunderlyingGPCR-mediated presynap-
tic inhibition at central synapses remains unresolved. According
to collision coupling theory assuming free lateral diffusion of
receptors, G-proteins, and effectors within the cell membrane,
only receptors activated by agonist are capable of interacting with
G-proteins (Orly and Schramm, 1976; Tolkovsky and Levitzki,
1978). As this model encounters difficulty explaining signaling
specificity at the single-cell level, alternative models were pro-
posed that assume coupling between the signaling units without
agonist (precoupling) and formation of predetermined signaling
microdomains (Neubig et al., 1988; Neubig, 1994). However,
currently there is no experimental evidence supporting any of
these models in central synapses.
Recent advances in molecular biology and optical imaging
enabled real-time monitoring of intermolecular dynamics in liv-
ing cells by resonance energy transfer technology (Lohse et al.,
2008). These studies in heterologous expression systems, al-
though boosting our understanding of receptor/G-protein/effec-
tor coupling mechanisms, yielded conflicting results. Some
studies have suggested existence of precoupled complexes be-
tween GPCRs, G-proteins, and effectors such as G-protein-
activated inwardly rectifying K (GIRK) channels (Nobles et al.,
2005; Gale´s et al., 2006; Riven et al., 2006; Fowler et al., 2007), and
diffusion-determined collision coupling has been proposed by
others (Hein et al., 2005). The disparity between these results
emphasizes the need to study intermolecular dynamics in native
environments and at specialized subcellular compartments.
Among various presynaptic GPCRs, GABAB receptors are
widely expressed in the brain as autoreceptors and heterorecep-
tors (Wu and Saggau, 1997; Bettler et al., 2004). GABAB receptors
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are obligatory heterodimers, requiring two homologous sub-
units, GB1 and GB2, to function (Jones et al., 1998; Kaupmann et
al., 1998; White et al., 1998; Kuner et al., 1999). Molecular diver-
sity of GABABRs arises from two pharmacologically indistin-
guishable GB1 isoforms, 1a and 1b (Bettler et al., 2004), and from
auxiliary KCTD subunits (Schwenk et al., 2010). Transgenicmice
with targeted isoform-specific genetic deletions suggest that
GB1a-containing receptors (GB1aRs) are predominantly localized
at glutamatergic boutons, mediating presynaptic inhibition of
glutamate release (Vigot et al., 2006; Guetg et al., 2009). Activa-
tion of presynaptic GABAB receptors induces inhibition of syn-
aptic vesicle release through suppression of Ca2 flux (Wu and
Saggau, 1995; Takahashi et al., 1998; Laviv et al., 2010), although
several Ca2-independent mechanisms have been proposed as
well (Scanziani et al., 1992; Parnas et al., 2000; Sakaba andNeher,
2003). Recent quantitative proteomic study on molecular com-
position of CaV2 channel nano-environment suggests that
GABAB receptors strongly interact with CaV2.2 channels in the
brain (Mu¨ller et al., 2010).
Althoughmuch information has been gained on the structure
and function of GABAB receptors, several key questions remain
unresolved. First, does assembly of the presynaptic GB1aR–G–
CaV2.2 complex require synaptic activity or, alternatively, are the
signaling units precoupled in amacromolecular complex regard-
less of GABA-induced activation? Second, how does GABA affect
the microarchitecture of signaling complexes at individual syn-
aptic boutons? Third, are GB1aRs required for the complex for-
mation? And finally, if GB1aRs are indeed compartmentalized
with G subunits and CaV2.2 channels, how does it impact the
function of central synapses? To address these questions, we
integrated fluorescence resonance energy transfer (FRET)
spectroscopy, optical imaging of vesicle exocytosis, and pre-
synaptic calcium transients at individual presynaptic boutons in
cultured hippocampal neurons (Laviv et al., 2010). Our findings
suggest that GB1aRs, G-protein heterotrimers and CaV2.2 chan-
nels are precoupled in presynaptic hippocampal boutons. We
identified the proximal C-terminal domain of theGB1a protein as
an essential molecular domain mediating the GB1aR–G–
CaV2.2 signaling complex assembly but as dispensable for the
receptor and Gi/o activation. The structural segregation of
ligand-binding and complex-formation domains allowed us to
isolate the impact of signaling compartmentalization on presyn-
aptic function.Our findings suggest that ligand-induced receptor
activation is necessary but insufficient for presynaptic inhibition
and propose that precoupling of GB1aRs, G subunits, and
CaV2.2 channels in a signaling nano-domain is required for a
proper negative regulation of basal synaptic vesicle release at hip-
pocampal synapses.
Materials andMethods
Hippocampal cell culture. Primary cultures of CA3-CA1 hippocampal
neurons were prepared from newborn Wistar rats and 1a/, 1b/,
WT (BALB/c background) mice on postnatal days 0–2, as described
previously (Slutsky et al., 2004). The generation of the 1a/ and 1b/
mice has been described previously (Vigot et al., 2006). All animal exper-
iments were approved by the Tel Aviv University Committee on Animal
Care.
Molecular biology. Construction of fusion proteins has been described
previously: GB1a
CFP, GB1a
YFP, and Go
CFP (Fowler et al., 2007); pHluorin-
GB1a (Guetg et al., 2009); G1
YFP, G2
CFP (Riven et al., 2006); CFP-Epak-
YFP (van der Krogt et al., 2008); and CaV2.2
CFP (Altier et al., 2006).Wild
type and mutants of GB1a proteins used throughout the study were con-
structed and expressed in peYFP-N1 under control of CMV promoter.
Nontagged GB1a-WT protein was engineered by digestion of peYFP-N1-
GB1a-WT with AgeI/NotI, and then blunting and religation. GB1a-21-
YFP was created by overlap-extension PCR and subcloning into peYFP-
N1-GB1a-WT using BamHI/AgeI. Nontagged GB1a-21 was created by
digestion peYFP-N1-GB1a-21 with AgeI/NotI, and then blunting and
religation. Nontagged GB1a-SD receptor was engineered by overlap-
extension PCR and subcloning into EcoRI/BamHI sites of peYFP-N1
plasmid bearing the nontagged GB1a-WT receptor gene. GB1a-S269A-
YFP was created by overlap-extension PCR and subcloning into ApaI/
AgeI sites of peYFP-N1-GB1a-WT. Nontagged GB1a-S269A was
constructed by digestion of peYFP-N1-GB1a-S269A with AgeI/NotI, and
then blunting and religation. Nontagged GB1a-103 was created by PCR
and then subcloned into BamHI/NotI sites of peYFP-N1-GB1a-WT.
Nontagged GB1a-74 andGB1a-39 were described previously (Boyer et
al., 2009).
Transient cDNA transfections have been performed using
Lipofectamine-2000 reagents and neurons were typically imaged
18–24 h after transfection.
Confocal imaging. Hippocampal neurons were imaged using a Zeiss
LSM510 META confocal microscope (Carl Zeiss) using a 40  1.2 NA
water-immersion objective and FV1000 spectral Olympus confocal mi-
croscope using a 60  1.2 NA water-immersion objective. The experi-
ments were conducted at room temperature in extracellular Tyrode
solution containing the following (inmM):NaCl, 145; KCl, 3; glucose, 15;
HEPES, 10; MgCl2, 1.2; CaCl2, 1.2; pH adjusted to 7.4 with NaOH. To
isolateminiature synaptic activity, TTX (1M)was added to extracellular
solution.
FRET imaging. FRET imaging was carried as described previously
(Laviv et al., 2010). For spectral analysis, CFP was excited at 405 nm
(Zeiss) or at 442 nm (Olympus) and fluorescence emissionwasmeasured
between 400 and 700 nm, with a 10 nm  step size. To reduce phototox-
icity and photobleaching,most of the FRET experiments were performed
using a narrowed emission spectrum (460–560 nm) composed of CFP
peak (486  10 nm) and a YFP peak (534  10 nm) containing YFP
emission due to FRET, direct YFP excitation at 405 nm, and CFP emis-
sion tail. YFP was imaged at 514 nm (excitation) and 525–560 nm (emis-
sion). Photobleaching of YFP was performed with 514 nm laser line, at
2.3 mW of laser output. We used a single point activation module for
rapid and efficient multiregion bleaching. We typically photobleached
two to six boutons per imaged axon: bleach duration was 35 ms per
bouton with a 5 ms interval between boutons.
Image acquisition parameters were optimized for maximal signal-to-
noise ratio and minimal phototoxicity: 700 V photomultiplier voltage; 4
s/pixel scan speed, 0.05–0.18mW (514 nm) or 0.15–0.2 (440 nm) laser
output; 90–130 m pinhole; 512 512 pixels image size. Z-stacks were
collected from 3–4 m optical slice at 0.6–0.8 m steps; images were
then stacked using maximal intensity projection per pixel algorithm and
converted to a single 2D image for analysis. Images were acquired with-
out averaging.
Calculation of FRET efficiency. Donor dequenching due to the desen-
sitized acceptor was measured from CFP emission (460–500 nm) before
and after the acceptor photobleaching. FRET efficiency, E, was then cal-
culated using the equationE 1 IDA/ID, where IDA is the peak of donor
emission in the presence of the acceptor and ID is the peak after acceptor
photobleaching. To exclude potential contribution of donor/acceptor
ratio to FRET efficiency measurements, all FRET experiments were per-
formed under saturation conditions of acceptor over donor. Detection of
CFP/YFP signals was done using custom-written scripts in MATLAB
(MathWorks) as described previously (Laviv et al., 2010). Briefly, regions
of interest (ROIs) were marked at boutons that underwent YFP photo-
bleaching. Average intensity of ROIs was subtracted from background
ROI intensity in close proximity to the bouton. All the boutons that
exhibited YFP photobleaching by90% of initial fluorescence intensity
were included in the analysis. Nonbleached boutons at the same image
area were analyzed to ensure lack of nonspecific photobleaching due to
image acquisition.
Detecting presynaptic calcium transients. Fluorescent calcium indicator
Calcium Green 488 BAPTA-1 AM was dissolved in DMSO to yield a
concentration of 1 mM. For cell loading, cultures were incubated at 37°C
for 30 min with 3 M of this solution diluted in standard extracellular
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solution. Extracellular solution contained 20 M DNQX to block recur-
rent activity and 50 M APV to block calcium flux through NMDA
receptors. Imaging was performed using FV1000 Olympus confocal mi-
croscope, under 488 nm (excitation) and 510–570 nm (emission), using
500 Hz line scanning. Ca2 transients were quantified following averag-
ing of 10 traces. Integral was calculated for F/F per bouton before and
after baclofen application. Integration time windowwas 300ms, starting
from the end of the stimulus.
FM-based imaging and analysis. Activity-dependent FM1-43 and
FM4-64 styryl dyes have been used to estimate basal synaptic vesicle
exocytosis. Action potentials have been elicited by passing 50 mA con-
stant current for 1 ms (	50% above the threshold for eliciting action
potential) through two platinumwires, separated by	7mmand close to
the surface of the coverslip. The extracellular medium contained nonse-
lective antagonist of ionotropic glutamate receptors (kynurenic acid, 0.5
mM) to block recurrent neuronal activity. Synaptic vesicles were loaded
with 15 M FM4-64 in all the experiments with GFP/CFP/YFP transfec-
tion, and 10 M FM1-43 was used in all the nontransfected neurons. FM
was loaded by bathing the cultures in a medium containing dye. FM was
present 5 s before and 30 s after the electrical stimulation (600 stimuli at
20 Hz). After dye loading, external dye was washed away in Ca2-free
solution containing ADVASEP-7 (0.1 mM) to scavenge membrane-
bound FM. The fluorescence of individual syn-
apses was determined from the difference
between images obtained after staining and
after destining (F ). For detection of FM
puncta, F images have been analyzed (only
the puncta exhibiting 90% destaining were
subjected to analysis). Detection of signals has
been done using custom-written scripts in
MATLAB as described previously (Abramov
et al., 2009). Briefly, the following criteria were
used for signal detection: the fluorescence
intensity was 2 SDs above the mean back-
ground and the area of puncta was between 0.1
and 2 m2.
Chemical reagents. FM4-64 (SynaptoRed C2),
FM1-43 (SynaptoGreen C4), and Advasep-7
were purchased fromBiotium; baclofen, DNQX,
CGP35348, and CGP54626 from Tocris Biosci-
ence; TTX from Alomon Labs; TeTx, APV, and
kynurenic acid from Sigma-Aldrich; and PTX
fromCalbiochem.
Statistical analysis. Error bars shown in the
figures represent SEM. The number of boutons
is defined by n and the number of experiments
(cultures) by N. All the experiments were re-
peated at least in three different batches of
cultures. One-way ANOVAwith post hocDun-
nett’s or Bonferroni’s tests was used to com-
pare several conditions. Student’s unpaired t
tests were used in the experiments where two
populations of synapses were compared. Stu-
dent’s paired t tests were used when the same
population of synapses was tested before and
after treatment. *p 0.05; **p 0.01; ***p
0.001; n.s., nonsignificant.
Results
GABABRs, G-proteins, and CaV2.2
channels are precoupled at
hippocampal boutons
In presynaptic terminals, the GABABR is a
heterodimer of GB1a/GB2 subunits that
mediates GABA-dependent inhibition of
voltage-gated N-type Ca channels (Wu
and Saggau, 1995; Dittman and Regehr,
1996). Inhibition of CaV2.2 channels
occurs through a G-protein-dependent
mechanism (Takahashi et al., 1998). Using FRET to detect inter-
molecular associations between CFP/YFP-tagged proteins, we
examined whether presynaptic GABAB receptors interact with
CaV2.2 channels and G-proteins at individual hippocampal bou-
tons. We investigated possible associations between GB1aRs,
Go12 G-protein subunits, and CaV2.2 channels at boutons of
pyramidal hippocampal neurons using the following tagged pro-
teins (Fig. 1A): (1) YFP-tagged GB1a receptor subunit (GB1a
YFP)
(Fowler et al., 2007); (2) CFP-tagged 1 subunit of CaV2.2 chan-
nel (CaV2.2
CFP) (Altier et al., 2006); (3) CFP-taggedGo subunit,
where CFP is internally inserted after E94 (Go
CFP) (Fowler et al.,
2007); (4) G1 G-protein subunit N-terminally tagged to YFP
(G1
YFP) (Riven et al., 2006); and (5) G2 G-protein subunit
N-terminally tagged to YFP (G2
YFP) (Riven et al., 2006). All of
the tagged proteins were functionally characterized previously
(Altier et al., 2006; Riven et al., 2006; Fowler et al., 2007; Laviv et
al., 2010). Presynaptic localization of tagged GABAB receptors in
boutons was confirmed previously by colocalization of GB1a
YFP
withCFP-tagged synapsin Ia protein andwith FM4-64 dye (Laviv
Figure 1. GB1aRs, Go12 G-protein subunits, and CaV2.2 channels are precoupled at single hippocampal boutons. A, Rep-
resentative confocal images of pyramidal neuron axons in hippocampal cultures that were cotransfected withGB1a
YFP/CaV2.2
CFP,
GB1a
YFP/Go
CFP,GB1a
CFP/G1
YFP and CaV2.2
CFP/G1
YFP. Scale bars, 2m. B, FRET was detected betweenGB1a
YFP/CaV2.2
CFP
(n 33,N 7),GB1a
YFP/Go
*94CFP (n 53),GB1a
CFP/G1
YFP (n 45,N 10),GB1a
CFP/G2
YFP (n 21,N 4), CaV2.2
CFP/
G1
YFP (n31,N6) proteins underminiature synaptic activity at single hippocampal boutons. To verify FRET specificity, Ewas
measured between the CFP-tagged proteins of interest and nonrelated TNFR2
YFP. Error bars indicate SEM. ***p 0.001. C, FRET
efficiency is plotted for individual presynaptic boutons as function of CFP/YFP intensity ratio (FCFP/FYFP). No correlationwas found:
Spearman r is 0.14, 0.11,0.08, and 0.05 forGB1a
YFP/CaV2.2
CFP,GB1a
YFP/Go
*94CFP,GB1a
CFP/G1
YFP, and CaV2.2
CFP/G1
YFP,
respectively (p 0.5). D, FRET was detected betweenGB1a
YFP/CaV2.2
CFP (n 8, N 3),GB1a
YFP/Go
CFP (n 9, N 3),
GB1a
CFP/G1
YFP (n 8,N 3), and CaV2.2
CFP/G1
YFP (n 12,N 4) proteins in nonreleasing TeTx-pretreated hippocampal
boutons. E, FRET was detected betweenGB1a
YFP/CaV2.2
CFP (n 9, N 3),GB1a
YFP/Go
CFP (n 9, N 3),GB1a
CFP/G1
YFP
(n 10, N 3), and CaV2.2
CFP/G1
YFP (n 9, N 3) proteins in nonreleasing immature (4–5 DIV) hippocampal neurons.
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et al., 2010). We first examined the basal
FRET efficiency (E), determined by do-
nor (CFP) dequenching following ac-
ceptor (YFP) photobleaching (Laviv et
al., 2010), produced by spontaneous
miniature synaptic activity in the pres-
ence of tetrodotoxin (TTX). We de-
tected significant FRET efficiencies between
GB1a
YFP/CaV2.2
CFP (0.11  0.006, n  33),
GB1a/Go
94CFP (0.14  0.007, n 
53), GB1a
CFP/G1
YFP (0.22 0.005, n 45),
GB1a
CFP/G2
YFP (0.22 0.007, n 21), and
CaV2.2
CFP/G1
YFP (0.22 0.006, n 31).
On average, FRET efficiencies for all the
tested protein pairs were significantly
higher (p  0.0001, mean E varied from
0.12 to0.23between thepairs) thannonspe-
cific FRET between CFP-tagged proteins of
interest and a nonrelated tumor necrosis
factor receptor 2, C-terminally tagged with
YFP (TNFR2
YFP) (2%) (Fig. 1B). Fur-
thermore, background enhancement of
CFP emission, assessed by photobleaching
at 514 nm in neurons expressing only GB1a
CFP,
was negligible (0.016 0.002, n 26) (Fig.
1B). FRET efficiency did not depend on
the donor-to-acceptor ratio (Fig. 1C).
Therefore, FRET measurements suggest
close association of the receptor and
G-proteins (GB1a/Go
94CFP; GB1a
CFP/G1
YFP;
GB1a
CFP/G2
YFP), the channel andG-proteins
(CaV2.2
CFP/G1
YFP) and, interestingly, be-
tween the receptor and channel (GB1a
YFP/
CaV2.2
CFP), inhippocampal boutonsunder
miniature synaptic activity.
To assess whether miniature synap-
tic activity is required for induction of
GB1aR–G-protein–CaV2.2 channel asso-
ciations, we examined FRET efficiencies
within the tagged proteins of interest un-
der resting conditions in boutons that are incapable of vesicle
recycling and, therefore, lack vesicular GABA release. To accom-
plish this, we measured FRET in tetanus toxin (TeTx) treated
neurons, in which SNARE-mediated vesicle release is inhibited
(Fig. 1D) and in immature boutons of young (4–5DIV) neurons
(Fig. 1E). Notably, basal FRET increased by 	50% between
GB1a
YFP/Go
CFP (p 0.01) and GB1a
YFP/CaV2.2
CFP (p 0.05), and it
decreased by 	45% between GB1a
CFP/G1
YFP (p  0.0001) and by
	35% between CaV2.2
CFP/G1
YFP (p  0.001) proteins in both
young and TeTx-treated neurons. Together, these data suggest
that (1) GB1a, Go1g2 G-protein, and CaV2.2 channel are preas-
sembled in the absence of GABA release; and (2) miniature
GABA release triggers rearrangement in the signaling complex,
promoting FRET between precoupled GB1a/G1g2 and CaV2.2/
G1 proteins, while reducing FRET between theGB1a/CaV2.2 chan-
nel and GB1a/Go proteins.
Agonist-induced rearrangements within the GB1aR
signaling complex
To further assess activity-dependent intermolecular conforma-
tional changes within the GB1aR signaling complex, we explored
effects of GABABR agonist and antagonist on FRET between the
tested protein pairs. For the receptor and channel, FRET between
GB1a
YFP and CaV2.2
CFP proteins decreased by	60% following ap-
plication of 10 M baclofen (n  13–20, p  0.0001) (Fig. 2A,
left). Conversely, the GABAB receptor antagonist CGP54626 (1
M) triggered a 	40% increase in GB1a
YFP/CaV2.2
CFP FRET (n 
14, p  0.01) (Fig. 2A, right). CGP54626 did not affect E in the
absence of neurotransmitter release (n  8, p  0.6). We next
examined the effect of pertussis toxin (PTX), which uncouples
the Gi/o subunit from the receptor. Baclofen did not alter FRET
between GB1a
YFP/CaV2.2
CFP proteins in PTX-treated neurons
(0.12  0.012 vs 0.115  0.011 for control and PTX-treated
neurons, respectively, n  7–8, p  0.8), indicating functional
coupling with the receptor was required for baclofen effect. For the
receptor and G-protein, baclofen significantly decreased GB1a
YFP/
Go
CFP FRET (0.05  0.002, n  12, p  0.0001) (Fig. 2B, left),
similar to a previous study (Frank et al., 2005). Pretreatment with
PTX abolished baclofen-induced FRET changes (0.13  0.013 vs
0.14 0.02 for control and PTX-treated neurons, respectively, n
13, p 0.2). CGP35348 (1 M) induced a	70% increase in FRET
(0.23 0.009, n 13, p 0.0001) (Fig. 2B, right) but had no effect
in the absence of neurotransmitter release (n  8–16, p  0.4).
Together, these data suggest that quantal GABA release weakens
association between precoupledCaV2.2 channel/GB1a receptor sub-
unit and GB1a/Go proteins.
Figure 2. Agonist-induced structural rearrangements in the GB1aR/G-protein/CaV2.2 channel complex. A, E between
GB1a
YFP/CaV2.2
CFPwas reduced by baclofen (10M, left,n 13–29,N 4–6, ***p 0.0001), butwas increased by CGP54626
(1M, right, n 14,N 4, **p 0.01).B, E betweenGB1a
YFP/Go
CFPwas reduced by baclofen (10M, left, n 12–17,N
4, ***p 0.0001), but was increased by GABABR antagonist CGP35348 (1M, right, n 13–18, N 4, ***p 0.0001). C, E
betweenGB1a
CFP/G1
YFP was increased by baclofen (10M, left, n 12–15, N 4, ***p 0.0001), but was decreased by
GABABR antagonist CGP54626 (1M, right, n 15, N 4, ***p 0.0001). D, E betweenG1
YFP/CaV2.2
CFP was increased by
baclofen (10M, left, n 14–27, N 4–6, ***p 0.0001), but was decreased by CGP54626 (1M, right, n 14–17, N
4–5, ***p 0.0001). Error bars indicate SEM. E, Fluorescence intensity of pHluorin tagged to GB1a does not change under
miniature activity, by application of 10M baclofen and as function of stimulation frequency (10 and 100 Hz). Slope of linear fit is
1.04, 0.98, 1.01, and 0.99 for miniature activity, baclofen application, 10 and 100 Hz, respectively.
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In contrast to GB1a/CaV2.2 and GB1a/Go interactions, ago-
nist promoted FRET between GB1a/G1 and CaV2.2/G1 pro-
teins. Baclofen produced a	30% increase in GB1a
CFP/G1
YFP FRET
(n 14–27, p 0.0001) (Fig. 2C, left), and CGP54626 reduced
FRET by	48% (n 14–17, p 0.0001) (Fig. 2C, right). FRET
efficiency between CaV2.2
CFP and G1
YFP proteins was increased
by baclofen by 	32% (n  14–15, p  0.0001) (Fig. 2D, left),
whereas it was decreased byCGP54626 antagonist by	47% (n
16–22, p 0.0001) (Fig. 2D, right). These data indicate that basal
GABA promotes GB1a/G1 and CaV2.2/G1 associations in hip-
pocampal boutons.
To test whether a reduction in FRET between GB1a/CaV2.2 or
between GB1a/Go by GABA might be explained by receptor in-
ternalization, we used pHluorin, a pH-sensitive GFP, tagged to
the N terminus of GB1a protein to monitor surface expression
of the GB1a under physiological conditions. Fluorescence of
pHluorin-GB1a was unchanged by stimulation frequencies of 10
Hz or even 100 Hz spikes, or by maximal receptor activation (10
M baclofen; Laviv et al., 2010) (Fig. 2E). These results suggest
that reduction in the number of membrane receptors is unlikely
to occur under our experimental conditions.
GB1a is required for G/CaV2.2 association
Having observed that binding of GABA to theGB1a subunit is not
essential for the precoupling of the GB1aR signaling complex,
suggesting the formation of a receptor–G-protein– channel
complex, we investigated whether the GB1a protein is essential
for G/CaV2.2 interactions. Therefore,
we measured possible FRET between
G1
YFP and CaV2.2
CFP in boutons of hip-
pocampal neurons prepared from GB1a
knock-out (Vigot et al., 2006) (1a/)
mice (Fig. 3A). Surprisingly, boutons
lacking GB1a protein revealed no specific
FRET between CaV2.2
CFP and G1
YFP pro-
teins under miniature synaptic activity
(0.03 0.004, n 31) (Fig. 3B). Further-
more, neither block of synaptic activity
nor agonist application induced specific
FRET signals in 1a/ boutons (n 10–
18) (Fig. 3B).We also observed no specific
FRET between CaV2.2
CFP and either
N-terminally tagged G2
N
-YFP (0.02 
0.01, n  10) or C-terminally tagged
G2
C
-YFP (0.03  0.006, n  9)
G-proteins (Fig. 3C). By contrast, signifi-
cant FRET (p  0.0001) was observed
between G2
C
-YFP/CaV2.2
CFP (0.12 
0.006, n  10) and between G2
N
-YFP/
CaV2.2
CFP (0.23 0.005,n 15) proteins
in boutons of WT neurons, suggesting
that there were no constraints on fluoro-
phore mobility. Notably, CaV2.2
CFP/
G1
N
-YFP FRET was not altered in GB1b
knock-out (1b/) boutons (0.18 0.01,
n 7), consistent with the idea that GB1a
and not GB1b is targeted to excitatory pre-
synaptic boutons (Vigot et al., 2006). To
confirm that FRET disruption was spe-
cific to the GB1a deletion, we examined
CaV2.2
CFP/G1
YFP interactions following
ectopic expression of GB1a protein in
1a/ neurons. Indeed, expression of
GB1a protein rescued the CaV2.2
CFP/G1
YFP FRET in 1a/ bou-
tons (0.15  0.01, n  17) (Fig. 3B). Moreover, FRET between
GB2
YFP receptor subunit and CaV2.2
CFP channel was abolished in
1a/ comparedwithWTneurons (n 8, p 0.0001) (Fig. 3D).
Thus, deletion of the GB1a protein disrupts association of key
signaling molecules, CaV2.2 channel and G12 (Fig. 3E).
Proximal C-terminal GB1a domain controls G–CaV2.2
channel interaction
Next, we searched for the molecular domain in the GB1a protein
that mediates assembly of the GB1aR–G–CaV2.2 channel sig-
naling complex.We created a series ofGB1a deletions/truncations
and tested whether expression of genetically modified GB1a ver-
sus wild-type GB1a (GB1a-WT) proteins in 1a
/ neurons dis-
rupts CaV2.2
CFP/G1
YFP FRET. To rule out a possible role for the
endogenous GB1a subunit, we examined all of the truncations
in the 1a/ cultures. First, we examined whether the GB1a
N-terminal sushi domains, functioning as axonal targeting sig-
nals (Biermann et al., 2010), mediate the G/CaV2.2 interac-
tion. Deletion of two sushi domains in the GB1a (G28-Q157,
GB1a-SD) (Fig. 4A) did not abolish G1
YFP/CaV2.2
CFP FRET
(0.13 0.009, n 15) (Fig. 4B). In addition, S269Amutation in
the GB1a protein (GB1a-S269A), which was shown to decrease by
10-fold the affinity toward GABA (Galvez et al., 2000), resulted
in CaV2.2
CFP/G1
YFP FRET as well (0.13 0.01, n 14) (Fig. 4B).
These results confirm our previous data showing significant
FRET between CaV2.2 and G in the absence of GABA binding
Figure 3. Disruption of FRET between the receptor, CaV2.2 channel, and G at hippocampal boutons of 1a
/ neurons. A,
Confocal images of axonal part of 1a/ hippocampal pyramidal neuron that was cotransfected with CaV2.2
CFP andG1
YFP.
Scale bar, 2m. B, Lack of specific FRET between CaV2.2
CFP and G1
N
-YFP in 1a/ boutons: under miniature synaptic activity
(Cnt, n 31, N 6), in the presence of 10M baclofen (n 16, N 4), and in TeTx-treated (n 14, N 3) and young (n
14, N 4) neurons. Transfection of 1a/ neurons with GB1a resulted in rescue of CaV2.2
CFP/G1
N
-YFP FRET (n 17, N 4,
***p 0.0001). C, Lack of specific FRET between CaV2.2
CFP and either G2
N
-YFP (n 10, N 3) or G2
C
-YFP (n 9, N 3).
D, Disruption of specific FRET between CaV2.2
CFP and GB2
YFP protein in 1a/ neurons (n 8, N 3, ***p 0.0001). E,
Diagram illustrating disruption of CaV2.2
CFP/G1
YFP FRET in boutons of 1a/ neurons. One-way ANOVA analysis with post hoc
Bonferroni’s multiple comparison tests (B) and paired t test (C, D) indicated significance. Error bars indicate SEM.
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(Fig. 1D,E) and suggest that agonist-
induced activation of the receptor is not
essential for the CaV2.2/G association.
Next, we tested whether the C termi-
nus of GB1a is responsible for the complex
assembly. Truncation of the entire C ter-
minus (at R857; GB1a-103) abolished
CaV2.2
CFP/G1
YFP FRET (0.024  0.002,
n 44) (Fig. 4B). To precisely identify the
site in GB1a C terminus that mediates
CaV2.2/G association, we created a se-
ries of C-terminal deletions/truncations:
deletion of the proximal domain of C ter-
minus (R857-S877; GB1a-21), trunca-
tion at the coiled–coiled domain (K886;
GB1a-74), and truncation of the distal
part of C terminus (L921; GB1a-39). No-
tably, GB1a-21 abolished CaV2.2
CFP/
G1
YFP FRET (0.036 0.007, n 24) (Fig.
4B). In contrast, neither GB1a-74 nor
GB1a-39 deletions prevented FRET be-
tween G1
YFP and CaV2.2
CFP (0.12 0.02,
n  14; and 0.10  0.01, n  17, respec-
tively). Together, these results suggest that
the proximalC-terminalGB1a domain is re-
quired forG–CaV2.2 channel association
at presynaptic boutons.
To assess whether the proximal C-
terminal domain of GB1a is essential for
intermolecular associations between
the receptor and CaV2.2 channel, we
measured FRET between YFP-tagged
GB1a-WT or GB1a-21 with CaV2.2
CFP.
The GB1a-21 deletion resulted in	54%
reduction of basal FRET (from 0.13 
0.02, n 20, in GB1a-WT to 0.06 0.008,
n 24, p 0.001) (Fig. 4C) and abolished
baclofen-induced decrease of FRET, which is typically observed
in GB1a-WT (Fig. 4C). In contrast, deletion of the proximal
C-terminal GB1a domain did not affect either basal FRET be-
tweenGB1a-21
YFP andGo
CFP or baclofen-induced FRET reduc-
tion (n  12–16, p  0.05) (Fig. 4D). These results suggest that
the proximal C-terminal GB1a domain mediates GB1aR–CaV2.2
channel interaction, whereas it is dispensable for association of
the GB1a with Go G-protein subunit.
Proximal C-terminal GB1a domain does not affect agonist-
induced GB1aR activation and cAMP inhibition
Next, we explored whether proximal C-terminal GB1a domain af-
fects agonist-induced activation of the GB1aR. Our previous work
suggests that agonist-induced increase in FRET between the
C-terminally tagged GB1a/GB2 receptor subunits reflects receptor
activation(Lavivet al., 2010).Therefore,wemeasured thepotencyof
baclofen to induce conformational changes in the GB1a
YFP/GB2
CFP re-
ceptor expressed in presynaptic boutons, comparing changes in re-
ceptors containing YFP-tagged GB1a-WT versus GB1a-21
proteins. Baclofendose–response curve for FRETefficiencybetween
GB1a
CFP andGB2
YFP revealed no significant difference in ED50 between
GB1a-WTandGB1a-21 proteins (GB1a-WT: 0.82 0.003M, n
10–21; GB1a-21: 0.58 0.05M, n 11–21) (Fig. 5A).
As deletion of the proximal C-terminal domain did not affect
GB1a
YFP/Go
CFP FRET, we assessed the ability of the GB1a-21 mu-
tant to activate Gi/o protein by measuring effect of baclofen on
cAMP levels at individual synapses using CFP-Epac-YFP FRET
reporter (van der Krogt et al., 2008). Baclofen induced 	50%
increase in CFP-Epac-YFP FRET, indicating inhibition of cAMP
level inGB1a-WT-expressing boutons (n 30–32, p 0.05) (Fig.
5B). In contrast, baclofen did not affect CFP-Epac-YFP FRET in
1a/ boutons (n  25–26, p  0.05) (Fig. 5B). In GB1a-21-
expressing boutons, baclofen induced a 	60% increase in FRET
(n 27–35, p 0.05) (Fig. 5B). Together, these results suggest that
the proximal C-terminal GB1a domain does not affect agonist-
induced GB1aR activation and Gi/o-dependent signaling.
Proximal C-terminal GB1a domain is essential for
agonist-induced presynaptic inhibition
Having established the necessity of GB1a protein for CaV2.2–G
association, we examined the functional role of the GB1a protein
and its proximal C-terminal domain in presynaptic inhibition of
Ca2 flux and synaptic vesicle release. First, we compared inhib-
itory effect of baclofen on presynaptic Ca2 transients in func-
tional boutons of 1a/ neurons versus boutons expressing
GB1a-WT or GB1a-21 proteins. Presynaptic Ca
2 transients
evoked by low-frequency stimulation were measured by high-
affinity fluorescent calcium indicator Oregon Green 488
BAPTA-1 AM (Laviv et al., 2010). Baclofen affected the size of
action-potential-dependent fluorescence transients (F/F) in
1a/ boutons by 10  1.7% (n  31), and it induced signifi-
cantly higher reduction of calcium transients in GB1a-WT-
expressing boutons (26.2 1.7% inhibition, n 17, p 0.001)
Figure4. Proximal C-terminal domain of the GB1a protein is essential for G/CaV2.2 channel association.A, Schematics show
GB1a constructs used to examine the domain responsible for G/CaV2.2 association. SD, Two sushi domains; LBD, ligand-binding
domain; 7TM, seven-transmembrane domain; PCT, proximal C-terminal domain; CC, coiled– coiled domain; DCT, distal C-terminal
domain.B, Mean FRET for the indicated transfection conditions in 1a/ neurons: GB1a-WT (n 66,N 11), GB1a-103 (n
44, N 8, **p 0.01), GB1a-21 (n 24, N 6, **p 0.0001), GB1a-74 (n 14, N 4, p 0.05), GB1a-39 (n 17,
N 4, p 0.05), GB1a-SD (n 15, N 4, p 0.05), and GB1a-S269A (n 14, N 4, p 0.05). One-way ANOVA analysis
with post hocDunnett’smultiple-comparison tests relative to 1a/boutons transfectedwithGB1a-WT indicated significance. C,
Effect of 10 M baclofen on theGB1a
YFP/CaV2.2
CFP FRET in 1a/ boutons transfected with GB1a-WT (n 7–20, N 3–5,
**p 0.01) or GB1a-21 (n 23–24,N 5–6, p 0.05).D, Effect of 10M baclofen on theGB1a
YFP/Go
CFP FRET in 1a/
boutons transfected with GB1a-WT (n 12–15, N 3–4, *p 0.05) or GB1a-21 (n 14–16, N 3–5, *p 0.05, paired t
test). Error bars indicate SEM.
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(Fig. 6A,B). Notably, GB1a-21-expressing boutons displayed
reduced sensitivity of Ca2 transients to baclofen compared with
GB1a-WT-expressing boutons (14.8  3% inhibition, n  19,
p  0.01) (Fig. 6A,B), suggesting that baclofen-induced inhibi-
tion of N-type calcium channels depends on the proximal
C-terminal domain of the GB1a receptor subunit.
Next, we assessed the role of the proximal C-terminal GB1a
domain on baclofen-induced inhibition of synaptic vesicle exo-
cytosis using FM4-64 dye (Laviv et al., 2010). The total pool of
recycling vesicles was stained bymaximal stimulation (600 APs at
10Hz) and subsequently destained by 1Hz stimulation. Baclofen
(10M) profoundly decreased the destaining rate constant (mea-
sured as 1/decay, whereas decay is an exponential time course) in
WT (N 12, p 0.001) (Fig. 7A,F), but it affected the destain-
ing rate by a much lesser extent in WT neurons expressing
membrane-targeted G scavenger, N-myristoylated phosducin
(Rishal et al., 2005) (MyrPhd, N  4, p  0.001) (Fig. 7B,F).
Furthermore, baclofen did not affect the destaining rate in 1a/
(N  9, p  0.3) (Fig. 7C,F) boutons, complementing electro-
physiological data on the lack of baclofen effect on basal synaptic
transmission in 1a/ CA3-CA1 synapses (Vigot et al., 2006).
Transient expression of GB1a-WT protein together with GFP in
1a/ neurons resulted in recovery of the inhibitory effect of
baclofen (N 6, p 0.001, compared with GFP-expressing neu-
rons) (Fig. 7D,F). Moreover, transient expression of the GB1a-
21 together with GFP in 1a/ neurons significantly reduced
baclofen effect on the destaining rate constant (N  6, p 
0.0001, compared with expression of GB1a–WTGFP-in 1a
/
neurons) (Fig. 7E,F). These results strongly suggest that (1) the
GB1a protein is essential for baclofen-induced inhibition of syn-
aptic vesicle release, (2) G is a mediator of baclofen-induced
presynaptic inhibition, and (3) the proximal C-terminal GB1a
domain is essential for baclofen-induced inhibition of synaptic
vesicle release in hippocampal boutons.
Discussion
In the current study, we discovered that the GABAB1a subunit
plays a crucial role in creating a functional receptor–G-protein–
channel complex in presynaptic boutons of hippocampal neu-
rons. First, we found that the presynaptic GB1aR, heterotrimeric
Go-protein and CaV2.2 channel are precoupled, forming macro-
molecular complex regardless of synaptic activity and agonist
stimulation at individual hippocampal boutons. Second, basal
GABA levels are sufficient to induce rearrangements within the
complex. Third, intermolecular associations within the receptor,
G, and CaV2.2 channel complex require expression of the GB1a
protein. Fourth, we identified the proximal C-terminal domain in
the GB1a protein as essential motif for the complex formation. This
Figure 5. The GB1a proximal C-terminal domain does not affect baclofen-induced GB1a/GB2
receptor activation and cAMP inhibition. A, Dose–response curves of baclofen on GB1a
CFP/
GB2
YFP FRET efficiency for GB1a-WT (n 10–21, N 5, ED50 0.82 0.003 M) and
GB1a-21 (n 11–21, N 3–5, ED50 0.58 0.013M) proteins. E at 100M baclofen
was set as 100%. B, Effect of 10M baclofen on CFP–Epac–YFP FRET efficiency (EEpac), report-
ing cAMP level, in 1a/ boutons and in 1a/ boutons expressing GB1a-WT or GB1a-21
proteins. Baclofen increased EEpac in GB1a-WT-expressing (n 30–32,N 6, *p 0.05) and
GB1a-21-expressing (n 27–35, N 5–6, *p 0.05) boutons, but did not affect EEpac in
1a/ boutons (n 25–26, N 5, p 0.05) One-way ANOVA with post hoc Bonferroni’s
multiple-comparison tests indicated significance. Error bars indicate SEM.
Figure6. The role of theGB1a proximal C-terminal domainonbaclofen-induced inhibitionof
Ca 2 transients. A, Baclofen did not affect spike-dependent presynaptic Ca 2 transients
(F/F ) evoked by 0.2Hz stimulation in 1a/boutons and in GB1a-21-expressing boutons,
but reduced it in GB1a-WT-expressing boutons. Ca
2 transients were quantified as before
(black) and after (gray) baclofen application (average of 10 traces). B, Average data on
baclofen-induced modification in Ca 2 transients in 1a/ (n 31, N 6, p 0.05),
GB1a-WT-expressing (n 17,N 4, ***p 0.001, comparedwith 1a
/), and GB1a-21-
expressing (n 19,N 5, p 0.05, comparedwith 1a/) boutons. One-way ANOVAwith
post hoc Bonferroni’smultiple-comparison tests indicated significance. Error bars indicate SEM.
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domain is required specifically for baclofen-
induced presynaptic inhibition of Ca2
transients and vesicle release, but not for the
receptor activation and cAMP inhibition.
Together, these findings suggest that
compartmentalization of the presynaptic
signaling complex, in addition to agonist-
induced receptor activation, critically
controls the GB1aR-mediated presynaptic
inhibition at hippocampal boutons.
PresynapticGABABR–G-protein–CaV2.2
channel signaling complex
Intermolecular interactions between re-
ceptors, G-proteins, and high-voltage-
gated Ca2 channels represent key events
in inhibition of neurotransmitter release.
Accumulating biochemical and electro-
physiological evidence suggests that direct
membrane-delimited interaction of Ca2
channel1 subunit withGmediates in-
hibition of presynaptic calcium currents
and of synaptic vesicle exocytosis byGPCRs
(Dascal, 2001; Dolphin, 2003; Tedford and
Zamponi, 2006; Catterall and Few, 2008).
Yet, the mechanisms of intermolecular
coupling remain controversial. Although
“physical scaffolding” of signaling compo-
nents within the same G-protein-coupled
signaling unit has been proposed to en-
hance signaling specificity (Neubig, 1994;
Tsunoda et al., 1997), direct evidence for
compartmentalization of GPCR signaling at central synapses is
still missing.
To explore the microarchitecture and dynamics of proteins in
specialized presynaptic compartments, FRET spectroscopy has
been used. Our data provide direct evidence for the close (100
Å) proximity between the taggedGB1aR, Go12 G-protein het-
erotrimer, and CaV2.2 channel (Fig. 1). Specific FRET signals
were detected in boutons lacking SNARE-mediated exocytosis,
under block of receptor activation by antagonist, and in boutons
expressingmutatedGB1a-S269A proteinwith reduced affinity for
GABA. These FRET-based data resonate with the recent pro-
teomic study onmolecular nano-environment of the CaV2 chan-
nels in the rodent brain (Mu¨ller et al., 2010). The authors
demonstrated direct interaction between the GABAB receptor
subunits and CaV2.2 channel under high stringency conditions.
However, lack of interaction between the GABAB receptor and
CaV2.2 channel was observed under resting conditions by coim-
munoprecipitation in sensory dorsal root ganglion neurons
(Puckerin et al., 2006), suggesting possible differences in signal-
ing complex organization at central versus peripheral synapses.
Furthermore, a direct interaction between CaV2.2 and G
G-protein subunits in the CNS has been also demonstrated by
proteomic studies (Khanna et al., 2007; Mu¨ller et al., 2010). To-
gether, FRET-based and proteomic analyses strongly suggest as-
sembly of the GABAB receptor presynaptic signaling complexes
under resting conditions in central synapses.
What is the molecular mechanism underling the GB1aR-
mediated presynaptic inhibition at hippocampal synapses? One
possibility is that presynaptic inhibition arises from reduction in
the number of available signaling molecules at the plasma mem-
brane of boutons. For example, agonist-induced cointernaliza-
tion of CaV2.2 channel with GPCRs such as opioid-like-receptor
ORL1 and dopamine D1 receptor have been observed in earlier
studies (Altier et al., 2006; Altier andZamponi, 2008; Kisilevsky et
al., 2008). To test whether the membrane fraction of GB1aRs
depends on activity-dependent concentration of GABA in the
vicinity of boutons, we measured fluorescence of pHluorin,
N-terminally tagged to the GB1a protein as function of neuronal
activity or agonist stimulation.We did not observe any change in
the pHluorin fluorescence as function of stimulation frequency
or agonist concentration (Fig. 2E), suggesting that under physi-
ological conditions, reduction in the number of GB1aRs at the
presynaptic membrane does not contribute to presynaptic inhi-
bition at hippocampal boutons. In addition, agonist-induced,
receptor-independent internalization of CaV2.2 channel might
mediate presynaptic inhibition as has been suggested in dorsal
root ganglion neurons (Tombler et al., 2006). However, this
mechanism seems to be G-independent, and our results sug-
gest that the GB1aR-mediated presynaptic inhibition in hip-
pocampal synapses is mediated by G (Fig. 7F).
Our data favor themodel based on agonist-induced structural
rearrangements within the GB1aR–G–CaV2.2 channel com-
plex as the mechanism mediating inhibition of basal synaptic
vesicle exocytosis. Although synaptic activity was not essential for
the complex formation, quantal synaptic transmission, an ele-
mentary unit of synaptic communication, induced structural re-
arrangements between the presynaptic signaling units (Fig. 2).
Tonic activation of the GB1aR complex under miniature synaptic
activity (in the presence of TTX) was relieved following applica-
tion of the receptor antagonist. Thus, basal levels of GABA in the
synaptic cleft are sufficient to activate GB1aRs through induction
of conformation changes in the GB1a/GB2 heterodimer (Laviv et
Figure 7. The GB1a proximal C-terminal domain is required for baclofen-induced inhibition of synaptic vesicle release. A–E,
Representative FM destaining curves before and after application of 10 M baclofen in WT cultures (n 84, A), WT cultures
transfectedwithMyrPhd and GFP (n 112,B), 1a/ cultures (n 71, C), 1a/ cultures transfectedwith GB1a-WT and GFP
(n69,D), and1a/ cultures transfectedwithGB1a-21andGFP (n94,E).F, Summary of baclofen effect on FMdestaining
rate in WT (N 12), GFP-expressing boutons (N 3), WT cultures transfected withMyrPhd and GFP (N 4), 1a/ (N 9),
1a/ transfectedwith GB1a-WT and GFP (N 6), and 1a
/ transfectedwith GB1a-21 and GFP (N 6) cultures. Error bars
indicate SEM. (***p 0.001, n.s. for p 0.05, one-way ANOVA analysis with post hoc Bonferroni’s multiple-comparison tests).
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al., 2010), leading to activation of G-protein and closer associa-
tion of precoupled G subunits and CaV2.2 channels (Fig. 2G).
As a result of these conformational rearrangements, basal GABA
induces reduction of presynaptic calcium flux (Fig. 6) and con-
sequent inhibition of synaptic vesicle release in hippocampal
boutons (Fig. 7).
Proximal GB1a C-terminal domain is required for the GB1aR
complex formation
It first came as a surprise that FRET between CaV2.2/G was
reduced to background level in 1a/ boutons lacking GB1a pro-
tein (Fig. 3). Presynaptic expression of the tagged CaV2.2 chan-
nels and G subunits was not altered in 1a/ neurons,
suggesting a proper trafficking to the 1a/ boutons. The lack of
specific FRET was observed with both G1 and G2 proteins and
did not depend on the position of fluorophore tagging, suggest-
ing that there were no constraints on fluorophore mobility that
could convert changes in orientation into substantial changes in
FRET. Therefore, these results suggest that reduction in donor–
acceptor distance, rather than dipole–dipole orientation of the
donor and acceptor fluorophores, underlies FRET disruption.
Neither alterations in synaptic activity nor agonist-induced stim-
ulation triggered the complex formation. This association was
recovered following transient expression of the GB1a-WTprotein
in 1a/ neurons. Notably, partial rescue of CaV2.2/G associ-
ation was observed following expression of the GB1a-S269A pro-
teinwith10-fold reduced affinity toGABA (Galvez et al., 2000).
These results led to the conclusion that the GB1a protein is essen-
tial for precoupling of the receptor, G, and CaV2.2 channel.
What is the GB1a molecular domainmediating formation of the
GB1aR signaling complex at hippocampal boutons? Previous work
suggested that the C terminus of the GB1 receptor subunit is not
essential for the GABAB receptor activation detected through GIRK
channel activity (Margeta-Mitrovic et al., 2001). Based on these re-
sults, the authors concluded that the GB1 protein is not required for
specific coupling to G-protein and its activation. Our findings con-
firm that C terminus of the GB1a protein is not required for activa-
tion of the receptor, receptor/Gi/o interaction, and cAMP
inhibition.Conversely, ourdata strongly suggest that theGB1a prox-
imal C-terminal domain (R857-S877) is required for a tight associ-
ation between the receptor, G, andCaV2.2 channel. Functionally,
deletion of this GB1a domain impaired presynaptic inhibition of
Ca2 flux and of synaptic vesicle exocytosis. These results imply
differential regulation of GIRK and CaV2.2 channels by the GB1a C
terminus. Thus, in addition to agonist-induced receptor activation,
preassembly of the GB1aR–G–CaV2.2 channel signaling complex
is essential for agonist-induced presynaptic inhibition at hippocam-
pal boutons. It will be interesting to explore functional significance
of GB1 proximal C-terminal domain on regulation of voltage-gated
Ca2 channels andNMDAreceptors in spines anddendrites (Chali-
foux and Carter, 2010, 2011).
Does association of G and CaV2.2 channel result from con-
stitutive activity of GB1aRs expressed at hippocampal boutons?
Unfortunately, no information is available on constitutive activ-
ity of presynaptic GB1aRs in central synapses. Our data provide
no evidence for constitutive GB1aR activity because CGP54626
antagonist, which works as a partial agonist at constitutively ac-
tive GABABRs (Mukherjee et al., 2006), did not affect any tested
association between the GB1aR, G subunits, and CaV2.2 chan-
nel in the absence of GABA (data not shown). Therefore, our
results imply that GB1a plays an essential role in coordinating and
integrating the complex assembly regardless of agonist-induced
receptor activation.
Individual hippocampal boutonsmay express diverse GPCRs,
in addition to GB1a/GB2 receptors, raising the question of the
mechanisms of GPCR-mediated signaling in 1a/ boutons
lacking functional G12/CaV2.2 signaling complexes. Presynap-
tic inhibition mediated through adenosine (Vigot et al., 2006)
and muscarinic (Vertkin and Slutsky, unpublished data) recep-
tors remains functional in 1a/ hippocampal synapses. These
data imply that adenosine and muscarinic receptors are capable
of presynaptic inhibition through distinct Ca2-dependent
and Ca2-independent mechanisms. For example, adenosine-
induced presynaptic inhibition is not limited to the N-type cal-
cium channel (Wu and Saggau, 1994; Dittman and Regehr,
1996). Moreover, M2 muscarinic receptors can inhibit neu-
rotransmitter release through direct block of release machinery
(Parnas and Parnas, 2007). Further work is needed to understand
the precise mechanisms underlying signaling specificity at syn-
apses expressing multiple GPCRs.
Together, our data support the “physical scaffolding” model of
GPCR, G-protein, and effector suggesting a precoupling of presyn-
aptic G-protein signaling complexes in central synapses. Our study
revealed the proximal C-terminal part of GB1a receptor subunit as
essential domain for a tight association of the receptor, G sub-
units, andCaV2.2channel.As theGB1aproximalC-terminaldomain
does not affect receptor activation, identification of this motif al-
lowed us, for the first time, to isolate functional significance under-
lyingprecouplingof signalingunits in amacromolecular complex. It
remains to be seen whether compartmentalization of GPCRs, G
subunits, and CaV2.2/1 channels constitutes a general mechanism
underlying presynaptic inhibition at central synapses.
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